Pediatrix Medical Group annual revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Pediatrix Medical Group Revenue Growth & History (MD)
Pediatrix Medical Group reported $1.91B in revenue for fiscal 2025, a decrease of 4.92% from the previous fiscal year.
View full Pediatrix Medical Group company overviewPediatrix Medical Group annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.91B | −$99.1M | −4.92% |
| 2024 | 2024-12-31 | $2.01B | $18.3M | +0.92% |
| 2023 | 2023-12-31 | $1.99B | $22.6M | +1.15% |
| 2022 | 2022-12-31 | $1.97B | $60.8M | +3.18% |
| 2021 | 2021-12-31 | $1.91B | $177.2M | +10.22% |
| 2020 | 2020-12-31 | $1.73B | −$45.8M | −2.57% |
| 2019 | 2019-12-31 | $1.78B | $56.7M | +3.29% |
| 2018 | 2018-12-31 | $1.72B | −$1.53B | −47.04% |
| 2017 | 2017-12-31 | $3.25B | $70.2M | +2.21% |
| 2016 | 2016-12-31 | $3.18B | — | — |
Pediatrix Medical Group quarterly revenue
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $487.8M | $18.9M | +4.04% |
| Q1 2026 | 2026-03-31 | $476.2M | $17.8M | +3.89% |
| Q4 2025 | 2025-12-31 | $493.8M | −$8.6M | −1.71% |
| Q3 2025 | 2025-09-30 | $492.9M | −$18.3M | −3.58% |
| Q2 2025 | 2025-06-30 | $468.8M | −$35.5M | −7.03% |
| Q1 2025 | 2025-03-31 | $458.4M | −$36.7M | −7.42% |
| Q4 2024 | 2024-12-31 | $502.4M | $5.9M | +1.19% |
| Q3 2024 | 2024-09-30 | $511.2M | $4.5M | +0.90% |
| Q2 2024 | 2024-06-30 | $504.3M | $3.7M | +0.74% |
| Q1 2024 | 2024-03-31 | $495.1M | $4.1M | +0.83% |
| Q4 2023 | 2023-12-31 | $496.4M | −$17.4M | −3.39% |
| Q3 2023 | 2023-09-30 | $506.6M | $16.7M | +3.41% |
| Q2 2023 | 2023-06-30 | $500.6M | $14.5M | +2.99% |
| Q1 2023 | 2023-03-31 | $491.0M | $8.8M | +1.82% |
| Q4 2022 | 2022-12-31 | $513.8M | $15.3M | +3.07% |
| Q3 2022 | 2022-09-30 | $489.9M | −$3.0M | −0.62% |
| Q2 2022 | 2022-06-30 | $486.0M | $13.1M | +2.76% |
| Q1 2022 | 2022-03-31 | $482.2M | $35.5M | +7.94% |
| Q4 2021 | 2021-12-31 | $498.5M | $81.9M | +19.66% |
| Q3 2021 | 2021-09-30 | $492.9M | $32.3M | +7.02% |
| Q2 2021 | 2021-06-30 | $473.0M | $57.5M | +13.85% |
| Q1 2021 | 2021-03-31 | $446.8M | $5.5M | +1.25% |
| Q4 2020 | 2020-12-31 | $416.6M | −$42.0M | −9.15% |
| Q3 2020 | 2020-09-30 | $460.6M | $5.7M | +1.26% |
| Q2 2020 | 2020-06-30 | $415.4M | −$23.7M | −5.40% |
| Q1 2020 | 2020-03-31 | $441.2M | $14.2M | +3.31% |
| Q4 2019 | 2019-12-31 | $458.6M | −$429.8M | −48.38% |
| Q3 2019 | 2019-09-30 | $454.9M | −$393.8M | −46.40% |
| Q2 2019 | 2019-06-30 | $439.2M | −$425.8M | −49.23% |
| Q1 2019 | 2019-03-31 | $427.1M | −$425.5M | −49.91% |
| Q4 2018 | 2018-12-31 | $888.4M | −$22.4M | −2.46% |
| Q3 2018 | 2018-09-30 | $848.8M | −$20.2M | −2.32% |
| Q2 2018 | 2018-06-30 | $865.0M | $22.0M | +2.62% |
| Q1 2018 | 2018-03-31 | $852.6M | $17.0M | +2.04% |
| Q4 2017 | 2017-12-31 | $910.8M | — | — |
| Q3 2017 | 2017-09-30 | $869.0M | — | — |
| Q2 2017 | 2017-06-30 | $842.9M | — | — |
| Q1 2017 | 2017-03-31 | $835.6M | — | — |
Pediatrix Medical Group revenue growth trends
Over the last five reported fiscal years, revenue grew from $1.73B to $1.91B, a compound annual growth rate of 1.99%. Pediatrix Medical Group's latest reported quarter, Q2 2026, generated $487.8M in revenue, an increase of 4.04% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Pediatrix Medical Group source filings ↗